2014
DOI: 10.1007/s00253-014-5713-8
|View full text |Cite
|
Sign up to set email alerts
|

Construction of helper plasmid-mediated dual-display phage for autoantibody screening in serum

Abstract: M13 filamentous bacteriophage has been used in displaying disease-specific antibodies, biomarkers, and peptides. One of the major drawbacks of using phage in diagnostic assays is the aspecific adsorption of proteins leading to a high background signal and decreasing sensitivity. To deal with this, we developed a genetically pure, exchangeable dual-display phage system in which biomarkers and streptavidin-binding protein (SBP) are displayed at opposite ends of the phage. This approach allows for sample purifica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…The first one, alkaline phosphatase, or green fluorescent protein (GFP), was located on the head, and the other, anti-CEA scFv, on the tail of the lambda phage [ 237 ]. A similar approach was used by Rajaram et al, who also created a dual-display system [ 238 ] in which a biomarker and a short peptide containing the streptavidin-binding motif Histidine-Proline-Glutamine (HPQ) were displayed on the opposite ends of the M13 bacteriophage capsid. This additional second peptide with a high affinity to streptavidin was introduced to allow for sample (phage) purification on streptavidin-conjugated magnetic beads to increase assay sensitivity and decrease background signal.…”
Section: Intranasal Administrationmentioning
confidence: 99%
“…The first one, alkaline phosphatase, or green fluorescent protein (GFP), was located on the head, and the other, anti-CEA scFv, on the tail of the lambda phage [ 237 ]. A similar approach was used by Rajaram et al, who also created a dual-display system [ 238 ] in which a biomarker and a short peptide containing the streptavidin-binding motif Histidine-Proline-Glutamine (HPQ) were displayed on the opposite ends of the M13 bacteriophage capsid. This additional second peptide with a high affinity to streptavidin was introduced to allow for sample (phage) purification on streptavidin-conjugated magnetic beads to increase assay sensitivity and decrease background signal.…”
Section: Intranasal Administrationmentioning
confidence: 99%
“…As with PhoPhabs, 44 the physical separation of genes encoding fusion proteins on two separate vectors (i.e., phagemid plus plasmid/designed helper phage) allows for simple combination of various binding and detection components on phage scaffold without the need for laborious genetic engineering of each individual probe. Another example of trans modular phage biosensor design was reported by Rajaram et al 46 They prepared filamentous virions concomitantly displaying a short streptavidin-binding peptide on p7 expressed from a helper plasmid, and phagemid-encoded UH-RA.21, a 28-amino-acid rheumatoid arthritis autoantigen, fused to p6. The helper plasmid lacked a packaging signal; therefore, recombinant phages were produced only upon transduction of host cells with phagemid virions.…”
Section: Bipartite Phage Display: Combining Twomentioning
confidence: 99%
“…21 as a biomarker and streptavidin (STV)-binding protein (SBP) as capturing peptide, both being displayed at opposite ends of a filamentous phage. 12 This approach resulted in a higher sensitivity of signal detection assays using STV-coated magnetic beads. Specifically, the dual phage displayed a biomarker (autoantigenic target UH-RA.21 specific for rheumatoid arthritis) fused to a coat protein pVI at one end and an anchoring SBP fused to a coat protein pVII at the other end.…”
mentioning
confidence: 99%